Liver disease in the Era of Coronavirus Disease 19 (COVID-19) pandemic
Open Access
- 20 October 2020
- journal article
- Published by Heighten Science Publications Corporation in Annals of Clinical Gastroenterology and Hepatology
- Vol. 4 (1), 052-057
- https://doi.org/10.29328/journal.acgh.1001023
Abstract
Coronavirus infections have caused outbreaks in humans: SARS-COV ((Severe Acute Respiratory Syndrome) and MERS-CoV (Middle East Respiratory Syndrome) resulting in significant mortality and morbidity.Keywords
This publication has 23 references indexed in Scilit:
- Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in SingaporeJAMA, 2020
- Transmission routes of 2019-nCoV and controls in dental practiceInternational Journal of Oral Science, 2020
- Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, ChinaPublished by Cold Spring Harbor Laboratory ,2020
- Clinical Features of COVID-19-Related Liver DamagePublished by Cold Spring Harbor Laboratory ,2020
- Pathological findings of COVID-19 associated with acute respiratory distress syndromeThe Lancet Respiratory Medicine, 2020
- Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV InfectionPublished by Cold Spring Harbor Laboratory ,2020
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingThe Lancet, 2020
- Influenza virus infection as precipitating event of acute-on-chronic liver failureJournal of Hepatology, 2019
- Kupffer Cell-Dependent Hepatitis Occurs during Influenza InfectionThe American Journal of Pathology, 2006
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003